p18SMI-21 is a novel INK4C inhibitor, specifically blocking the bioactivity of p18 protein. References: Isaac O, Thiemer K. [Biochemical studies on camomile components/III. In vitro studies about the antipeptic activity of (--)-alpha-bisabolol (author's transl)]. Arzneimittelforschung. 1975 Sep;25(9):1352-4. German. PubMed PMID: 21.

纯度：≥98%

CAS：20535-76-6